newsfilter
← Latest News
GlobeNewswire·

Crescent Biopharma Announces Grants of Inducement Awards

  • Crescent Biopharma's Compensation Committee approved equity inducement awards on June 25, 2026.
  • The awards consist of options to purchase 65,100 aggregate shares for three non-executive employees.
  • Grants were made under the 2025 Employment Inducement Incentive Award Plan & were material to employment acceptance per Nasdaq Rule 5635(c)(4).
  • Options carry a 10-year term with an exercise price of $16.99 per share.
  • Vesting begins with 25% of shares on the first anniversary of the start date, followed by monthly vesting of 1/48th of shares thereafter.
  • Vesting is contingent upon continuous service with the company through applicable dates.
  • Crescent Biopharma is a clinical-stage oncology company with a pipeline including a PD-1 x VEGF bispecific antibody & antibody-drug conjugates.